• Sherica Celine
    Sherica Celine
    • 7 months ago
    • Practical Guidance Journal
    • pa

    To Give or Not to Give: The Provision of Anti-Overdose Medication in the Workplace

    By: Angela R. Cabral and Chelsea R. Avent , SLOAN SAKAI YEUNG & WONG LLP SYNTHETIC OPIOIDS, SUCH AS FENTANYL, ARE RESPONSIBLE for thousands of deaths in California every year. 1 Nationwide, deaths due to overdose rose 30% between 2019 and 2020 and...
  • Sherica Celine
    Sherica Celine
    • over 3 years ago
    • Practical Guidance Journal
    • pa

    Determining Spread Adjustments for SOFR Loans

    By: The Practical Guidance Finance Team This article discusses credit spread adjustments related to the differential in rates between the London Interbank Offered Rate (LIBOR) and the Secured Overnight Financing Rate (SOFR). While LIBOR and SOFR historically...
  • Sherica Celine
    Sherica Celine
    • over 1 year ago
    • Practical Guidance Journal
    • pa

    Generative AI in Discovery: GPT Prompt Preservation and Production Best Practices

    By: Rose J. Hunter Jones, Kassi R. Burns, and Meredith A. Perlman, KING & SPALDING THIS ARTICLE DISCUSSES BEST PRACTICES AND STRATEGIC INSIGHTS LITIGATORS SHOULD CONSIDER IN A FEDERAL COURT LITIGATION when dealing with discovery produced by generative...
  • Sherica Celine
    Sherica Celine
    • over 2 years ago
    • Practical Guidance Journal
    • pa

    Wage and Hour Issues Related to Remote and Hybrid Work: A Fertile Delta for Litigation

    By: Laurie E. Leader EDITOR-IN-CHIEF, BENDER’S LABOR AND EMPLOYMENT BULLETIN Everyone agrees that the COVID-19 pandemic has changed the way we work. Even as pandemic numbers wane, employers have continued to allow remote work schedules and hybrid...
  • Vinayak Kohli
    Vinayak Kohli
    • over 5 years ago
    • Practical Guidance Journal
    • pa

    Data Integrity Risk Management for Life Sciences Companies

    By: Scott Bass and Deeona Gaskin , Sidley Austin LLP This article addresses key topics related to the management of data by drug, biologic, and medical device companies whose products are regulated by the U.S. Food and Drug Administration (FDA). This...
<>